Fatty liver disease ranges from completely harmless to life-threatening, depending on which of its four stages you’re in. Most people with early-stage fatty liver will never develop serious liver problems. But for the roughly 3 to 5% who progress to cirrhosis, the consequences include liver failure, liver cancer, and death. The bigger, less obvious risk applies to everyone with the condition: heart disease is actually the leading cause of death in people with fatty liver, not liver disease itself.
The Four Stages, From Mild to Severe
Fatty liver disease progresses through a predictable sequence, though most people never make it past the first stage.
- Stage 1: Simple fatty liver. Fat accumulates in your liver cells, but there’s no damage. Your liver works normally. This is the most common stage by far, and many people stay here their entire lives.
- Stage 2: Steatohepatitis (NASH). The fat buildup has triggered inflammation. Your liver isn’t seriously damaged yet, but you’re now at risk of scarring.
- Stage 3: Fibrosis. Scar tissue is forming in your liver. It still functions reasonably well at this point, but stopping further damage becomes critical.
- Stage 4: Cirrhosis. Severe scarring has permanently changed your liver’s structure and impaired its ability to function. This stage carries the risk of internal bleeding, liver failure, liver cancer, and life-threatening infections.
Progression to cirrhosis occurs in about 3% of patients over 15 years, and the full journey from early fatty liver to cirrhosis often takes more than 20 years. That slow timeline is both reassuring and dangerous. It’s reassuring because most people have plenty of time to intervene. It’s dangerous because the disease is almost completely silent in its early stages, which means many people don’t know they have it until significant damage has already occurred.
Why It’s Usually a Silent Condition
Fatty liver disease often has no symptoms at all. When symptoms do appear, they tend to be vague: fatigue, a general feeling of being unwell, or mild discomfort in the upper right side of your abdomen. None of these are specific enough to point clearly to a liver problem.
Most people discover they have fatty liver incidentally, through blood work or imaging done for another reason. A liver elastography scan (sometimes called a FibroScan) can measure both the amount of fat in your liver and the degree of scarring. A normal liver has less than 5% fat content, and a stiffness reading between 2 and 7 kilopascals suggests no significant scarring. Readings of 14 kilopascals or higher indicate cirrhosis.
Heart Disease Is the Bigger Threat
This is the part that surprises most people. While liver complications get all the attention, cardiovascular disease is the principal cause of death in people with fatty liver disease. A scientific statement from the American Heart Association confirmed that fatty liver is an independent risk factor for heart attack and stroke, even after accounting for the usual suspects like high blood pressure, cholesterol, and diabetes.
The numbers are striking. Studies have found that people with fatty liver face roughly 1.5 to 2 times the risk of cardiovascular events compared to those without it, and some research in specific populations shows the risk climbing even higher. One study found a hazard ratio of 4.1 for nonfatal cardiovascular events. In people with type 1 diabetes and biopsy-confirmed fatty liver, the odds of coronary artery disease and other vascular problems were 7.6 times higher than in those without liver fat.
This means that even if your liver never progresses beyond stage 1, the metabolic dysfunction driving the fat accumulation is simultaneously raising your risk of a heart attack. Treating fatty liver disease isn’t just about protecting your liver.
Liver Cancer Risk With Cirrhosis
For people who do reach cirrhosis, liver cancer becomes a real concern. The annual incidence of hepatocellular carcinoma (the most common type of liver cancer) in people with fatty liver-related cirrhosis is about 3.8 per 100 people per year. That rate is similar to the liver cancer risk seen in people with cirrhosis from other causes, like hepatitis or heavy alcohol use. Regular screening with imaging improves the chances of catching cancer early, but the risk reinforces why preventing progression to cirrhosis matters so much.
How Common It Is
Fatty liver disease is now the most common chronic liver condition worldwide. As of 2023, an estimated 1.3 billion people globally are living with it, roughly 16% of the world’s population. Men are affected at slightly higher rates than women. The condition has also been rising in children and adolescents, with a global prevalence of about 4.7% in that age group. Boys are affected nearly twice as often as girls.
The medical community recently renamed the condition from “nonalcoholic fatty liver disease” (NAFLD) to “metabolic dysfunction-associated steatotic liver disease” (MASLD). The new name better reflects what’s actually happening: fatty liver is almost always linked to metabolic problems like excess weight, high blood sugar, elevated triglycerides, or high blood pressure. If you have liver fat plus at least one of these cardiometabolic risk factors, the current diagnosis is MASLD.
It Can Be Reversed, Especially Early On
The most important thing about fatty liver disease is that the early stages are reversible. Simple fat accumulation clears when the underlying metabolic drivers improve, and even inflammation can resolve. The primary tool is weight loss. Losing 10% or more of your total body weight is the threshold that predicts real improvement in liver scarring. In one study, 63% of patients who achieved that level of weight loss saw their fibrosis regress, compared to just 9% of those who didn’t.
That 10% target is significant but achievable. For someone weighing 200 pounds, it means losing 20 pounds. The weight loss doesn’t need to happen quickly. Gradual, sustained loss through dietary changes and physical activity is the approach with the strongest evidence. No specific diet has been proven superior, but reducing processed foods, sugar, and refined carbohydrates while increasing physical activity addresses the metabolic dysfunction that causes the fat to accumulate in the first place.
Children Face a Longer Timeline of Risk
Fatty liver disease in children and adolescents is particularly concerning because of the decades of potential progression ahead of them. Kids with fatty liver are more likely to already have cardiovascular risk factors and metabolic syndrome than their peers. Research on children with biopsy-confirmed fatty liver disease has found significantly higher rates of cancer, liver-related death, and cardiometabolic mortality later in life. Early identification and intervention in younger patients can potentially prevent decades of compounding damage to both the liver and the cardiovascular system.